ArticleObesity facts2026
Obesity Care Barriers in Kidney Transplant Candidates and Recipients: Perspectives from a Survey of Transplant Experts.
Article in Obesity facts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionWithin the kidney transplant community, there is growing recognition of the importance of treating obesity to improve access to and outcomes of kidney transplant. We sought to assess kidney transplant professionals' attitudes and practices regarding obesity management.
methodsThe American Society of Transplantation Kidney Pancreas Community of Practice Obesity Workgroup developed and administered a web-based survey to a broad audience of healthcare professionals working with potential kidney transplant candidates and recipients.
resultsWith 275 respondents from 113 kidney transplant programs representing >70% of US kidney transplant volume, we found that only 68% of kidney transplant programs with a weight management program reported access to an obesity medicine specialist. Among programs that prescribe anti-obesity medications, the majority prescribe nutrient-stimulated hormones, while few utilize other agents. Most kidney transplant professionals prefer that obesity medicine physicians lead obesity management in their patients; however, 74% reported that access to weight management programs was extremely or somewhat difficult, with 64% citing long wait times for an appointment as the main barrier to care.
conclusionsKidney transplant professionals believe that obesity medicine physicians are best suited to lead obesity treatment for their patients, though access to this care appears to be a major barrier.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.